489 related articles for article (PubMed ID: 21994774)
41. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
[TBL] [Abstract][Full Text] [Related]
42. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Nakamura T; Nishiura Y; Eguchi K
Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):137-49. PubMed ID: 20021347
[TBL] [Abstract][Full Text] [Related]
44. Nuclear export and expression of human T-cell leukemia virus type 1 tax/rex mRNA are RxRE/Rex dependent.
Bai XT; Sinha-Datta U; Ko NL; Bellon M; Nicot C
J Virol; 2012 Apr; 86(8):4559-65. PubMed ID: 22318152
[TBL] [Abstract][Full Text] [Related]
45. Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity.
Kannagi M; Hasegawa A; Kinpara S; Shimizu Y; Takamori A; Utsunomiya A
Cancer Sci; 2011 Apr; 102(4):670-6. PubMed ID: 21219540
[TBL] [Abstract][Full Text] [Related]
46. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
47. [Human T-lymphotropic virus type I (HTLV-I): risk of transmission with transfusion].
Lefrère JJ
Presse Med; 2000 Jun; 29(20):1134-8. PubMed ID: 10901796
[TBL] [Abstract][Full Text] [Related]
48. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
[TBL] [Abstract][Full Text] [Related]
49. An Update on the Global Epidemic of Human T-Cell Lymphotrophic Virus Type-I (HTLV-I).
Edlich R; Hill LG; Williams FM
J Long Term Eff Med Implants; 2017; 27(2-4):355-368. PubMed ID: 29773049
[TBL] [Abstract][Full Text] [Related]
50. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
Yasuma K; Yasunaga J; Takemoto K; Sugata K; Mitobe Y; Takenouchi N; Nakagawa M; Suzuki Y; Matsuoka M
PLoS Pathog; 2016 Jan; 12(1):e1005372. PubMed ID: 26735971
[TBL] [Abstract][Full Text] [Related]
51. Serological and Molecular Methods to Study Epidemiological Aspects of Human T-Cell Lymphotropic Virus Type 1 Infection.
Cassar O; Gessain A
Methods Mol Biol; 2017; 1582():3-24. PubMed ID: 28357658
[TBL] [Abstract][Full Text] [Related]
52. Human T-lymphotropic virus type I in Japan.
Yamaguchi K
Lancet; 1994 Jan; 343(8891):213-6. PubMed ID: 7904671
[TBL] [Abstract][Full Text] [Related]
53. The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns.
Abrams A; Akahata Y; Jacobson S
Viruses; 2011 Aug; 3(8):1320-31. PubMed ID: 21994781
[TBL] [Abstract][Full Text] [Related]
54. Immune responses to HTLV-I(ACH) during acute infection of pig-tailed macaques.
McGinn TM; Wei Q; Stallworth J; Fultz PN
AIDS Res Hum Retroviruses; 2004 Apr; 20(4):443-56. PubMed ID: 15157363
[TBL] [Abstract][Full Text] [Related]
55. Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis.
Olière S; Douville R; Sze A; Belgnaoui SM; Hiscott J
Cytokine Growth Factor Rev; 2011 Aug; 22(4):197-210. PubMed ID: 21924945
[TBL] [Abstract][Full Text] [Related]
56. Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes.
Belrose G; Gross A; Olindo S; Lézin A; Dueymes M; Komla-Soukha I; Smadja D; Tanaka Y; Willems L; Mesnard JM; Peloponese JM; Césaire R
Blood; 2011 Sep; 118(9):2483-91. PubMed ID: 21505188
[TBL] [Abstract][Full Text] [Related]
57. Expression of TSLC1 in patients with HAM/TSP.
Takenouchi N; Tanaka M; Sato T; Yao J; Fujisawa JI; Izumo S; Kubota R; Matsuura E
J Neurovirol; 2020 Jun; 26(3):404-414. PubMed ID: 32285300
[TBL] [Abstract][Full Text] [Related]
58. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
59. HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1.
Al-Saleem J; Dirksen WP; Martinez MP; Shkriabai N; Kvaratskhelia M; Ratner L; Green PL
PLoS One; 2019; 14(3):e0214059. PubMed ID: 30897179
[TBL] [Abstract][Full Text] [Related]
60. Comparative virology of HTLV-1 and HTLV-2.
Martinez MP; Al-Saleem J; Green PL
Retrovirology; 2019 Aug; 16(1):21. PubMed ID: 31391116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
